Draft guidance document on the collection and analysis of disaggregated data in clinical trials: Contact us

Direct your questions to the appropriate directorate in Health Canada:

Biologic and Radiopharmaceutical Drugs Directorate (BRDD)
Office of Regulatory Affairs
Health Products and Food Branch
Health Canada
Email: brdd.ora@hc-sc.gc.ca

Pharmaceutical Drugs Directorate (PDD)
Health Products and Food Branch
Health Canada
Email: pharma_drug_enquiries-renseignements_medicaments_pharma@hc-sc.gc.ca

Natural and Non-prescription Health Products Directorate (NNHPD)
Health Products and Food Branch
Health Canada
Email: nnhpd.consultation-dpsnso@hc-sc.gc.ca

Marketed Health Products Directorate (MHPD)
Health Products and Food Branch
Health Canada
Email: mhpd-dpsc@hc-sc.gc.ca

For questions or comments on this guidance document:

Centre for Policy, Pediatrics and International Collaboration
Biologic and Radiopharmaceutical Drugs Directorate
Health Products and Food Branch
Health Canada
Email: brdd-cppic_brdd-cppci@hc-sc.gc.ca